These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 33664577

  • 1. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
    Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang Y, Chen X, Chen X, Wang Z.
    Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
    [Abstract] [Full Text] [Related]

  • 2. Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC.
    Shao H, Zhang Y, Yan J, Ban X, Fan X, Chang X, Lu Z, Wu Y, Zong L, Mo S, Yu S, Chen J.
    Onco Targets Ther; 2021; 14():2163-2175. PubMed ID: 33790579
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
    Okazaki J, Tanahashi T, Sato Y, Miyoshi J, Nakagawa T, Kimura T, Miyamoto H, Fujino Y, Nakamura F, Takehara M, Ma B, Bando M, Kitamura S, Okamoto K, Muguruma N, Sogabe M, Takayama T.
    Digestion; 2020; 101(6):794-806. PubMed ID: 31563901
    [Abstract] [Full Text] [Related]

  • 4. Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression.
    Noda K, Sato Y, Okada Y, Nishida K, Kawano Y, Tanahashi T, Bando M, Okamoto K, Takehara M, Sogabe M, Miyamoto H, Daizumoto K, Kanayama H, Takayama T.
    Cancer Med; 2024 Oct; 13(20):e70265. PubMed ID: 39431622
    [Abstract] [Full Text] [Related]

  • 5. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
    Liang M, Yu S, Tang S, Bai L, Cheng J, Gu Y, Li S, Zheng X, Duan L, Wang L, Zhang Y, Huang X.
    Front Genet; 2020 Oct; 11():449. PubMed ID: 32508877
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Iwase H.
    Oncotarget; 2017 Sep 19; 8(41):69934-69944. PubMed ID: 29050253
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
    Shin B, Lee JY, Im Y, Yoo H, Park J, Lee JS, Lee KY, Jeon K.
    J Intensive Care; 2023 Aug 03; 11(1):35. PubMed ID: 37537685
    [Abstract] [Full Text] [Related]

  • 8. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
    Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM.
    Eur Urol Focus; 2016 Jun 03; 2(2):210-218. PubMed ID: 28723537
    [Abstract] [Full Text] [Related]

  • 9. Exosomal miRNA 16-5p/29a-3p from pancreatic cancer induce adipose atrophy by inhibiting adipogenesis and promoting lipolysis.
    Tien SC, Chang CC, Huang CH, Peng HY, Chang YT, Chang MC, Lee WH, Hu CM.
    iScience; 2024 Jul 19; 27(7):110346. PubMed ID: 39055920
    [Abstract] [Full Text] [Related]

  • 10. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 19; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

  • 11. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.
    Xin W, Fu Y, Chen L, Ding H, Feng T, Sun J, Qi Y, Hu Y, Fang Q, Fang L.
    J Gastrointest Oncol; 2023 Apr 29; 14(2):719-732. PubMed ID: 37201049
    [Abstract] [Full Text] [Related]

  • 12. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA, Rashid S, Singh N, Rashid S, Singh V, Gunjan D, Das P, Dash NR, Pandey RM, Chauhan SS, Gupta S, Saraya A.
    Sci Rep; 2021 Feb 02; 11(1):2824. PubMed ID: 33531550
    [Abstract] [Full Text] [Related]

  • 13. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.
    Guz M, Jeleniewicz W, Cybulski M, Kozicka J, Kurzepa J, Mądro A.
    Biomed Rep; 2021 Jan 02; 14(1):10. PubMed ID: 33235725
    [Abstract] [Full Text] [Related]

  • 14. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S.
    J Exp Clin Cancer Res; 2019 Jul 15; 38(1):310. PubMed ID: 31307515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma.
    Chen L, Cao P, Huang C, Wu Q, Chen S, Chen F.
    J Cell Biochem; 2020 Jun 15; 121(5-6):3382-3391. PubMed ID: 31898829
    [Abstract] [Full Text] [Related]

  • 17. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.
    Makler A, Asghar W.
    Int J Mol Sci; 2023 Mar 07; 24(6):. PubMed ID: 36982154
    [Abstract] [Full Text] [Related]

  • 18. Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer.
    Wu Q, Yu L, Lin X, Zheng Q, Zhang S, Chen D, Pan X, Huang Y.
    Cancer Manag Res; 2020 Mar 07; 12():485-495. PubMed ID: 32021461
    [Abstract] [Full Text] [Related]

  • 19. Serum exosomal miR-141-3p and miR-3679-5p levels associated with endotype and postoperative recurrence in chronic rhinosinusitis with nasal polyps.
    Wang G, Liu Z, Zhan J, Li R, Ye Y, Qi Y, Wei X, Zheng J.
    World Allergy Organ J; 2024 Aug 07; 17(8):100938. PubMed ID: 39156601
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C.
    Clin Cancer Res; 2017 Sep 01; 23(17):5311-5319. PubMed ID: 28606918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.